Please login to the form below
pricing model
This page shows the latest pricing model news and features for those working in and with pharma, biotech and healthcare.
US start-up EQRx promises approach that will slash drug prices
EQRx is co-founded by Peter Bach, director of the Center for Health Policy and Outcomes at Memorial Sloan Kettering Cancer Center whose academic interests focus on pricing as well as ... Bach recently proposed a model for selecting drugs for pricing
Latest news
-
Senate grilling makes pharma CEOs squirm, but give little ground
a cap on Medicare out of pocket payments, and supported value-based payments as a future pricing model. ... grilling. Despite being a longstanding critic of pharma’s pricing, Grassley has also indicated he wants to work with the sector on reform if
-
Amgen CEO says Aimovig is “one of most successful launches”
The Repatha discount comes as the US administration is ramping up the pressure on the biopharma industry on drug pricing, most recently proposing a reference pricing model to bring process closer
-
US pricing plan slammed for imposing “foreign price controls”
Gellad also says in a blog post on Stat News that the plans are long on rhetoric but short on concrete plans to implement the reference pricing system, providing “just a
-
Safety first: AI adoption in the healthcare sector
Cost: agree a clear pricing model, which could be licence- or transaction-based and may also have elements of risk and reward.
-
Daily Brief: Charity criticises NHSE and Vertex over Orkambi access, Sema scores again, NodThera launched
evidence route which would demonstrate the benefits of the treatment and allow an outcomes-based pricing model.
More from news
Approximately 0 fully matching, plus 23 partially matching documents found.
Latest Intelligence
-
Assessing the risks in annuity pricing models
The challenge of adapting pricing models to accommodate new therapies. By Walter Colasante. ... pricing model.
-
Brexit and Trump
that we need to return to servicing a high-volume, low-cost model in consumer healthcare, and a parity pricing model in Rx.
-
Pharma deals in September 2015
to pursue a “robust” pricing model. ... Pharmaceuticals. He has also written a letter to employees to assuage their concerns over company's business model, potential exposure and the fall in the company's stock price (it fell
-
Interview: Richard Bergström, EFPIA
These are good examples of where legislation helps promote innovation, but unfortunately it's the access to markets, pricing and reimbursement that are deteriorating. ... I have worked very closely with the Swedish government to shape value-based-pricing.
More from intelligence
Approximately 0 fully matching, plus 4 partially matching documents found.
Latest from PMHub
-
Innovation in pharma: the highs and lows of the current healthcare economy
concerns. New entrants at both ends of the pricing spectrum. So while challenges remain, biosimilars seem to be finding their place in the market and creating a new and interesting dynamic, ... the system with a manageable pricing model to suit.
-
Ed Schoonveld - new article
Following the publication of the new edition of The Price of Global Health, Ed Schoonveld writes about the industry's need for new drug pricing model. ... Does the drug industry need a new pricing model? Read Ed Schoonveld's article here . The new
-
Emerging Markets: The Second Tier
Determine your pricing model: overcome governmental challenges and hear about what worked for Roche in Vietnam. ... Safeguard your reputation:employ a model of good corporate governance and learn how to overcome local corruptio n.
More from PMHub
Approximately 0 fully matching, plus 3 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
-
MEDICAL WRITER - HOME WORKING
-
Salary TBC
- Sales Director, Healthcare communications agency, London/ SE UK
-
Six figure salary
- ACCOUNT MANAGER / SENIOR ACCOUNT MANAGER
-
Salary TBC
-
SENIOR MEDICAL WRITER
-
Salary TBC
- Senior Account Director - Med Comms Agency
-
Salary TBC
- Sinovac’s COVID-19 vaccine appears safe in older adults
- Bayer’s finerenone scores FDA priority review for chronic kidney disease
- FDA authorises flexible storage for Pfizer/BioNTech COVID-19 vaccine
- AZ/Oxford University vaccine shows 82.4% efficacy with extended dosing schedule
- Pfizer/BioNTech vaccine is 94% effective after second dose, major real-world study finds
- UK introduces Rare Diseases Framework to improve the lives of people with rare diseases
- Live Webinar: There's No Going Back: How COVID-19 will Change Pharma Forever
- Live Webinar: Leading Successful Change Through Innovative Digital Technologies
- Living with psoriasis: a patient perspective
- UK study finds Pfizer/BioNTech, AZ/Oxford vaccines reduce severe COVID-19 in older people
- The imperfect art of sustainable communications
- AZ sells stake in Moderna for around $1.2bn
PMHub
11 London
The biggest problems facing humanity today are health-related, and the health of people, animals and our planet are inextricably linked. ...
Latest intelligence
- Good design saves lives
- Good design and creative thinking are essential if we are to improve on existing problems in new ways, which is why design and creativity within healthcare is vital. Health is...
- Why you must understand the pricing of patient recruitment companies
- Recruiting a diverse range of patients and engaging with them for your clinical trial isn’t an easy task, which means you might turn to patient recruitment companies, like us, who...
- A cultural shift in clinical research
- Research organisations across the board are experimenting with new technologies...
Quick links
Infographics
